XERIS PHARMACEUTICALS INC

CUSIP: 98422LAA5 Class: Bond 30/360P2 U

683 Capital Management, LLC's Holding History (CIK: 0001404574)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 3,200,000 Value ($000) $3,968 Avg Close — Range —
Q3 2024
Shares 3,200,000 Value ($000) $3,504 Avg Close — Range —
Q2 2024
Shares 3,200,000 Value ($000) $3,244 Avg Close — Range —
Q1 2024
Shares 3,200,000 Value ($000) $3,264 Avg Close — Range —
Q4 2023
Shares 2,950,000 Value ($000) $3,083 Avg Close — Range —
Q3 2023
Shares 2,950,000 Value ($000) $3,039 Avg Close — Range —
Q2 2023
Shares 2,950,000 Value ($000) $3,529 Avg Close — Range —
Q1 2023
Shares 2,950,000 Value ($000) $2,508 Avg Close — Range —
Q4 2022
Shares 5,950,000 Value ($000) $4,968 Avg Close — Range —
Q3 2022
Shares 7,950,000 Value ($000) $7,235 Avg Close — Range —
Q2 2022
Shares 7,950,000 Value ($000) $7,155 Avg Close — Range —
Q1 2022
Shares 7,950,000 Value ($000) $9,374 Avg Close — Range —
Q4 2021
Shares 7,950,000 Value ($000) $9,858 Avg Close — Range —
Q3 2021
Shares 7,950,000 Value ($000) $9,068 Avg Close — Range —
Q2 2021
Shares 8,450,000 Value ($000) $13,267 Avg Close — Range —
Q1 2021
Shares 8,600,000 Value ($000) $14,653 Avg Close — Range —
Q4 2020
Shares 8,100,000 Value ($000) $14,094 Avg Close — Range —
Q3 2020
Shares 7,500,000 Value ($000) $14,550 Avg Close — Range —
Q2 2020
Shares 10,000,000 Value ($000) $10,050 Avg Close — Range —